Effet des différents traitements de l'ostéoporose sur la prévention de la fracture: vers une approche individuelle et économique. [Effects of different treatments for osteoporosis on prevention of fractures: toward and individualized and economic approach]

Détails

ID Serval
serval:BIB_3391E25F5C13
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Effet des différents traitements de l'ostéoporose sur la prévention de la fracture: vers une approche individuelle et économique. [Effects of different treatments for osteoporosis on prevention of fractures: toward and individualized and economic approach]
Périodique
Schweizerische Rundschau fur Medizin Praxis
Auteur(s)
Lamy O., Krieg M. A.
ISSN
1013-2058 (Print)
Statut éditorial
Publié
Date de publication
03/2004
Volume
93
Numéro
11
Pages
399-405
Notes
Comparative Study English Abstract Journal Article --- Old month value: Mar 10
Résumé
The aim of this paper is to review the benefice of various antiosteoporotic treatment (calcium and vitamin D, raloxifene, bisphosphonates, calcitonin, PTH, strontium ranelate) and to discuss for which women with osteoporosis these treatments are efficient. The age, previous fractures, and bone mass measurement (T-score) identify women at high risk for subsequent fracture. The development of assessment tools for predicting fracture risk, the use of the NNT (number needed to treat), and economical analyses including QALY (quality-adjusted life-year) are particularly helpful. Economical analyses take into account the health care resources needed to get these benefits. At 50 years, only calcium and vitamin D are cost-effective, whereas at 70 years, bisphosphonates and raloxifene are also cost-effective.
Mots-clé
Aged Aged, 80 and over Alendronate/therapeutic use Calcitonin/therapeutic use Calcium/therapeutic use Cost-Benefit Analysis Diphosphonates/therapeutic use Female Fractures, Spontaneous/economics/*prevention & control Humans Middle Aged Osteoporosis, Postmenopausal/complications/*drug therapy/economics Parathyroid Hormone/therapeutic use Raloxifene/therapeutic use Selective Estrogen Receptor Modulators/therapeutic use Treatment Outcome Vitamin D/therapeutic use
Pubmed
Création de la notice
25/01/2008 14:55
Dernière modification de la notice
20/08/2019 14:19
Données d'usage